Fonte: American Journal of Nephrology. Unidade: FM
Assuntos: ANGIOTENSINA II, DOENÇA CRÔNICA, EVOLUÇÃO CLÍNICA, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUJIHARA, Clarice Kazue et al. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model. American Journal of Nephrology, v. 32, n. 2, p. 95-102, 2010Tradução . . Disponível em: https://doi.org/10.1159/000315137. Acesso em: 02 out. 2024.APA
Fujihara, C. K., Vieira Jr., J. M., Sena, C. R., Ventura, B. H., Malheiros, D. M., & Zatz, R. (2010). Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model. American Journal of Nephrology, 32( 2), 95-102. doi:10.1159/000315137NLM
Fujihara CK, Vieira Jr. JM, Sena CR, Ventura BH, Malheiros DM, Zatz R. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model [Internet]. American Journal of Nephrology. 2010 ; 32( 2): 95-102.[citado 2024 out. 02 ] Available from: https://doi.org/10.1159/000315137Vancouver
Fujihara CK, Vieira Jr. JM, Sena CR, Ventura BH, Malheiros DM, Zatz R. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model [Internet]. American Journal of Nephrology. 2010 ; 32( 2): 95-102.[citado 2024 out. 02 ] Available from: https://doi.org/10.1159/000315137
